New US Insurance Code Approved
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Control Bionics Ltd. announced the approval of a new US Healthcare Common Procedure Coding System code for its NeuroNode device, which will allow for reimbursement in the US healthcare system. This approval is expected to significantly enhance the accessibility and insurance coverage of NeuroNode for users with impaired speech and motor function. Control Bionics anticipates that this development will create substantial opportunities for growth and expansion in the US market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Control Bionics
- Share placement - North Star Impact Fund to invest
- TGA Approval Granted for DROVE Autonomous Wheelchair Module
- Control Bionics completes successful $1.04m placement
- Autonomous Wheelchair Project - US Research Award
- Completion of Placement of Rights Issue Shortfall
Later from Control Bionics
- Exclusive UK and Ireland Distribution Agreement
- Trading Halt
- Investor Presentation
- Non-Renounceable Issue
- Non-renounceable rights issue offer and private placement ad
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics